The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
3D index calculated from duration and severity of neutropenia and a degree of fever as prognostic factors predicting mortality of chemotherapy-induced febrile neutropenia in hematologic malignancies.
Ryosuke Shirasaki
No relevant relationships to disclose
Nobu Akiyama
No relevant relationships to disclose
Haruko Tashiro
No relevant relationships to disclose
Takuji Matsuo
No relevant relationships to disclose
Tadashi Yamamoto
No relevant relationships to disclose
Yoko Oka
No relevant relationships to disclose
Kazuo Kawasugi
No relevant relationships to disclose
Naoki Shirafuji
No relevant relationships to disclose